Apr.15 -- Kempen & Co Equity Analyst of Life Science Ingrid Gafanhao speaks to Bloomberg's Alix Steel about the Curevac Covid-19 vaccine and it's expected release now that variants are being taken into account. She speaks on "Bloomberg Markets: European Close".